IP Library Granted Patent US 10,578,625
Granted Patent B2
US 10,578,625 · App. 15/740,170 · Granted Mar 3, 2020

Method for analyzing posttranslational modifications using GEL IEF and mass spectrometry

Inventors: Peter Mats Oliviusson (Uppsala, SE); Janne Lehtio (Bandhagen, SE); Rui Miguel Mamede-Branca (Solna, SE)
Assignee: GE Healthcare Bio-Sciences AB
G01N33/6848C07K1/28G01N27/44795G01N27/4473G01N2440/00G01N2440/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,578,625
App. No.
15/740,170
Granted
Mar 3, 2020
Kind
B2
Abstract

The present invention relates to the field of proteomics and more specifically to a method for analyzing a sample possible containing peptides or modified peptides; in particular useful for biomarker discovery or validation of biomarkers. The method uses isoelectric focusing and mass spectrometry (MS) and enables identification of modified peptides with high resolution and predictability.

Claims (25)

1. A method for assaying a digested protein sample, comprising

a) running said sample on an isoelectric focusing gel with a pH gradient to separate peptides in said sample;

b) fractionating said gel into smaller pieces;

c) extracting peptides from the fractionated gel pieces;

d) running mass spectroscopy (MS) on the extracted peptides from selected fractions; and

e) identifying peptides and any possible post translational modification (PTM) of the peptides from step d) by identifying the modification degree of the peptides, and/or the position of the modification on the peptides,

wherein the peptides comprise phosphorylated peptides,

wherein extracted phosphorylated peptides from step c) are treated with alkaline phosphatase, and

wherein the pH-gradient is 2.5-3.7.

2. Method according to claim 1 , wherein the PTM comprises any modification changing the pI of the peptides.

3. Method according to claim 2 , wherein the PTM comprises at least one of glycolysations, alkylation, methylation, prenylation, or ubiquitination.

4. Method according to claim 1 , wherein the isoelectric focusing gel is 5-40 cm in length.

5. Method according to claim 1 , wherein the protein sample is trypsin digested.

6. Method according to claim 1 , wherein the sample is fractionated into 15-100 fractions.

7. Method according to claim 1 , wherein the extraction of peptides in step c) is performed with a hydrophobic solute under agitation, or convection heating.

8. Method according to claim 1 , wherein all fractions are selected in step d).

9. Method according to claim 1 , wherein a subset of fractions are selected in step d) and said subset is specific for a certain disease.

10. Method according to claim 9 , wherein samples from patients are screened in respect of presence of peptides in said subset of fractions.

11. Method according to claim 1 , wherein identifying peptides and any possible PTM of the peptides from step d) comprises identifying the modification degree of the peptides.

12. A method comprising:

running a digested protein sample on an isoelectric focusing gel with a pH gradient to separate peptides in said sample; and

identifying peptides and any possible post translational modification (PTM) of the peptides by identifying the modification degree of the peptides and/or the position of the modification on the peptides,

wherein the peptides comprise phosphorylated peptides and the phosphorylated peptides are treated with alkaline phosphatase before identifying the peptides, and

wherein the isoelectric focusing gel has a pH-gradient of 2.5-3.7.

13. Method according to claim 12 , wherein identifying peptides and any possible PTM of the peptides comprises identifying the modification degree of the peptides.

Assignments (2)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIO-SCIENCES AB
To: CYTIVA SWEDEN AB
Reel/Frame 054262/0184 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2017
From: OLIVIUSSON, PETER MATS; MAMEDE-BRANCA, RUI MIGUEL; LEHTIO, JANNE
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 044491/0776 →
Priority Claims (1)
GB 1512012.4 · Jul 9, 2015 · national
Continuity (1)
Related Publication 20180188263A1 · Jul 5, 2018